NCT01327027 - Vasopressin Effects on Human Social Communication | Biotech Hunter

Enrollment

225

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

April 30, 2017

Conditions

Healthy

Interventions

DRUG

Vasopressin, Arginine, ADH

Vasopressin will be dissolved in sterile saline and intranasally delivered in one of 2 doses to each subject (20IU, 40IU)

DRUG

Placebo; Sterile Saline

Sterile saline will be delivered intranasally on a second test day, in counterbalanced order with vasopressin administration.

Trial Locations (1)

Maine Medical Center, McGeachey Hall, OP Psych, Portland